Numbing shot for gender-affirming surgery pain
Part of Pain clinical trials.
This trial tests a numbing shot given during penile inversion vaginoplasty to see if it reduces pain after surgery. It might help people manage pain with less need for strong painkillers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are having penile inversion vaginoplasty (a type of gender-affirming surgery).
- You are not currently taking more than 30 mg of oxycodone (or an equivalent pain medicine) each day.
- You do not have an active infection where the shot would be given.
- You can speak and read English.
- This is your first vaginoplasty (not a revision) and not a vulvaplasty procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special numbing injection (called an erector spinae plane block) given near the spine during surgery can reduce pain after lumbar fusion. If you qualify, you might have less pain and need fewer painkillers after your operation.
This study compares two ways of delivering numbing pain medicine through a nerve catheter after surgery: a steady infusion versus scheduled bolus doses. It aims to see which method works better and is easier to use for post-operative pain control.
This study compares a “numbing shot” in the back (erector spinae block) against a placebo shot to see which better reduces pain. If you’re having a planned day surgery, it may help improve your comfort after the operation.
This trial tests if a numbing injection in the cervix area can reduce pain after minimally invasive prolapse surgery. If you're having this surgery, the study may help determine if the shot makes recovery more comfortable.
This study tests whether injecting the numbing medicine bupivacaine during sling surgery for stress incontinence can reduce pain right after surgery and for months afterward. It is a randomized double-blind trial, meaning neither you nor your doctor will know if you received bupivacaine or a placebo.
This Phase 3 study tests ways to manage pain during and after gender-affirming surgery while using less opioid medicine. It may help improve comfort after surgery and reduce opioid-related side effects.
Hear when a new Pain, Postoperative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.